Voyager Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. 

CEO
Alfred W. Sandrock
CEOAlfred W. Sandrock
Employees
162
Employees162
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2013
Founded2013
Employees
162
Employees162

VYGR Key Statistics

Market cap
413.77M
Market cap413.77M
Price-Earnings ratio
2.57
Price-Earnings ratio2.57
Dividend yield
—
Dividend yield—
Average volume
517.76K
Average volume517.76K
High today
$7.71
High today$7.71
Low today
$7.32
Low today$7.32
Open price
$7.40
Open price$7.40
Volume
345.05K
Volume345.05K
52 Week high
$14.34
52 Week high$14.34
52 Week low
$6.06
52 Week low$6.06

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.